![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JF Brien, BE McLaughlin, TH Breedon, BM Bennett, K Nakatsu and GS Marks
This study was conducted to test the hypothesis that biotransformation of glyceryl trinitrate (GTN) is involved in GTN-induced relaxation of vascular smooth muscle. Isolated rabbit aortic strips (RAS) were contracted submaximally with phenylephrine (PE) and then were incubated with 0.5 microM [14C]GTN in a time course study. GTN-induced relaxation (inhibition of PE-induced tone) of RAS was monitored and tissue GTN and glyceryl-1,2- and 1,3-dinitrate (GDN) concentrations were measured by thin-layer chromatography and liquid scintillation spectrometry at 0.5, 1, 2 and 20 min after incubation. Biotransformation of GTN to GDN occurred during GTN-induced relaxation of RAS. The tissue GDN concentration was dependent on the time duration of incubation with GTN and was related to the magnitude of GTN-induced tissue relaxation. At the 20-min interval, the GDN concentration in the incubation medium indicated appreciable efflux of GDN metabolites from the RAS. In the biotransformation of GTN by RAS, there was about 4-fold preferential formation of 1,2-GDN compared with 1,3-GDN. RAS were made tolerant to GTN in vitro by incubation with 500 microM GTN for 1 hr. After washing, GTN-tolerant and nontolerant (incubation with vehicle for 1 hr) RAS were contracted submaximally with PE, and then were incubated with 0.5 microM [14C]GTN for 2 min. GTN-induced relaxation of RAS and tissue GDN concentration were significantly less for GTN-tolerant tissue compared with nontolerant tissue. Tissue GTN concentration was similar for both GTN-tolerant and nontolerant RAS, which indicated that the tissue uptake of GTN was similar and that GTN biotransformation was diminished in tolerant tissue.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  J. D. MacPherson, T. D. Gillespie, H. A. Dunkerley, D. H. Maurice, and B. M. Bennett Inhibition of Phosphodiesterase 5 Selectively Reverses Nitrate Tolerance in the Venous Circulation J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 188 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kakutani, K. Ogawa, S. Iwahashi, K. Mizumoto, and Y. Hatano Sevoflurane Enhances Nitroglycerin Tolerance in Rat Aorta: Implications for the Desensitization of Soluble Guanylate Cyclase Possibly Through the Additive Generation of Superoxide Anions and/or Hydroxyl Radicals Within Vascular Smooth Muscle Anesth. Analg., October 1, 2005; 101(4): 1015 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, Z. Chen, F. R. Cobb, and J. S. Stamler Role of Mitochondrial Aldehyde Dehydrogenase in Nitroglycerin-Induced Vasodilation of Coronary and Systemic Vessels: An Intact Canine Model Circulation, August 10, 2004; 110(6): 750 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. DiFabio, Y. Ji, V. Vasiliou, G. R. J. Thatcher, and B. M. Bennett Role of Mitochondrial Aldehyde Dehydrogenase in Nitrate Tolerance Mol. Pharmacol., November 1, 2003; 64(5): 1109 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Chen, J. Zhang, and J. S. Stamler From the Cover: Identification of the enzymatic mechanism of nitroglycerin bioactivation PNAS, June 11, 2002; 99(12): 8306 - 8311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kim, S. D. Rybalkin, X. Pi, Y. Wang, C. Zhang, T. Munzel, J. A. Beavo, B. C. Berk, and C. Yan Upregulation of Phosphodiesterase 1A1 Expression Is Associated With the Development of Nitrate Tolerance Circulation, November 6, 2001; 104(19): 2338 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Ratz, A. B. Fraser, K. J. Rees-Milton, M. A. Adams, and B. M. Bennett Endothelin Receptor Antagonism Does Not Prevent the Development of In Vivo Glyceryl Trinitrate Tolerance in the Rat J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 578 - 585. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Ratz, J. J. McGuire, D. J. Anderson, and B. M. Bennett Effects of the Flavoprotein Inhibitor, Diphenyleneiodonium Sulfate, on Ex Vivo Organic Nitrate Tolerance in the Rat J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 569 - 577. [Abstract] [Full Text]
|
|
|
|
|
|
G. Kojda, M. Patzner, A. Hacker, and E. Noack Nitric Oxide Inhibits Vascular Bioactivation of Glyceryl Trinitrate: A Novel Mechanism to Explain Preferential Venodilation of Organic Nitrates Mol. Pharmacol., March 1, 1998; 53(3): 547 - 554. [Abstract] [Full Text]
|
|
|
|
|
|
A. Mulsch, P. Mordvintcev, E. Bassenge, F. Jung, B. Clement, and R. Busse In Vivo Spin Trapping of Glyceryl Trinitrate–Derived Nitric Oxide in Rabbit Blood Vessels and Organs Circulation, October 1, 1995; 92(7): 1876 - 1882. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
